Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 37, 2583-2588, August 1, 1977]
© 1977 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barlogie, B.
Right arrow Articles by Bodey, G. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barlogie, B.
Right arrow Articles by Bodey, G. P.

Lethal and Kinetic Effects of Peptichemio on Cultured Human Lymphoma Cells1

Barthel Barlogie, Benjamin Drewinko, Wolfgang Göhde and Gerald P. Bodey

Departments of Developmental Therapeutics [B. B., G. P. B.] and Laboratory Medicine [B. D.], The University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, Houston, Texas 77030, and Fachklinik Hornheide, University of MÜnster Medical School, Münster, Germany [W. G.]

The lethal and cytokinetic effects of peptichemio (multipeptide complex of m-[di(2-chloroethyl)amino]-L-phenylalanine), a polypeptide derivative of L-phenylalanine mustard, were investigated on a human lymphoma cell line (T1 cells) by means of colony formation and serial DNA histograms. One hr of exposure of exponentially growing T1 cells to increasing concentrations of peptichemio resulted in a biphasic exponential survival curve. Prolongation of drug treatment effected progressive reduction of D0 to a minimum of 0.25 µg/ml after 12 hr of incubation. One hr of exposure of synchronized cultures to 2.5 µg/ml killed cells in G1 and G2 more effectively than those in S phase. Cell cycle traverse was delayed in S and, more markedly, in G2. These kinetic perturbation effects increased with increasing drug concentrations and incubation times. Treatment of exponentially growing T1 cells with 10 µg/ml for >12 hr caused a largely irreversible S-phase arrest, reducing the degree of G2 accumulation observed after exposure to lower concentrations and/or shorter incubation times. The position of the cells in the cell cycle at the time of drug incubation (5.0 µg/ml, 1 hr) determined the extent and onset of subsequent G2 delay; cells in G1 and early S phase were blocked in the premitotic phase of their immediate lifespan, whereas late S and G2 cells underwent cell division without significant delay and were arrested in the G2 phase of the subsequent generation.

1 Supported by Contract N01-CM-53773 from the National Cancer Institute, Division of Cancer Treatment, and by Grant CA 14528 from the NIH, USPHS, Bethesda, Md. 20014.

Received 2/10/77. Accepted 5/ 6/77.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1977 by the American Association for Cancer Research.